ClearPoint Neuro (CLPT) vs CapsoVision (CV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CapsoVision (CV) has outperformed ClearPoint Neuro (CLPT) over the past year, gaining 38.9% versus a loss of 59.6%. CapsoVision is the larger company by market cap ($353.8 million vs $317.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLPT | CV |
|---|---|---|
| Share price | $10.42 | $6.65 |
| Market cap | $317.85M | $353.85M |
| 1-day change | -2.25% | +1.68% |
| YTD return | -22.08% | -38.82% |
| 1-year return | -59.61% | +38.85% |
| 5-year return | -40.65% | — |
| EPS (TTM) | $-1.18 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.10 | $15.37 |
| 52-week low | $8.27 | $4.38 |
| Distance from 52-week high | -65.38% | -56.73% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +125.53% | +42.86% |
| Average volume | 637.17K | 158.10K |
| Shares outstanding | 30.50M | 53.21M |
| Employees | 160 | 99 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CV has outperformed CLPT by 98.5 percentage points over the past year.
About ClearPoint Neuro
CLPT stock →ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
Health Care · Medical/Dental Instruments · 160 employees
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
CLPT vs CV FAQ
Which is bigger, ClearPoint Neuro or CapsoVision?
CapsoVision (CV) is larger, with a market capitalization of $353.85M compared with $317.85M for ClearPoint Neuro (CLPT).
Which stock has performed better over the past year, CLPT or CV?
CV returned +38.85% over the past 12 months, compared with -59.61% for CLPT (price return, excluding dividends). Past performance does not predict future results.
Are ClearPoint Neuro and CapsoVision in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for ClearPoint Neuro and Biotechnology: Electromedical & Electrotherapeutic Apparatus for CapsoVision.